Fixes Book Closure for Dividend & AGM
Merck Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from April 24, 2016 to April 26, 2016 (both days inclusive) for the purpose of Payment of Dividend & 49th Annual General Meeting (AGM) of the Company to be held on April 26, 2016. Board recommends Dividend
Merck Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 26, 2016, inter alia, has recommended a dividend at the rate of Rs. 7.50 (Rupees Seven and Fifty paise) per equity share of Rs. 10/- each for the year ended December 31, 2015. Standalone Financial Results, Form A, Auditors Report for December 31, 2015
Merck Ltd has informed BSE about : 1. Standalone Financial Results for the period ended December 31, 20152. Standalone Form A for the period ended December 31, 20153. Standalone Auditors Report for the period ended December 31, 2015 Board to consider Dividend
Merck Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 26, 2016, to consider and approve the audited financial results for the year ended December 31, 2015 and to consider recommendation of dividend for the year 2015. Merck Accelerator launches equity-free accelerator programme for digital health in Nairobi
The three-month programme will support three startups in the field of digital health with working space at the Nairobi Garage Merck has started its equity-free accelerator programme for digital health startups in Nairobi, Kenya. With this step, Merck takes the programmes presence to a global level. Currently, the company is also globally kicking off the [] Shareholding for the Period Ended December 31, 2015
Merck Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2015. For more details, kindly Click here Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015
Merck Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2015, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Patent Office refuses divisional application of Merck's antibiotic
The application lacked distinct invention from parent application, the Patent Officer said Closure of Trading Window
Merck Ltd has informed BSE that the Company has already issued notification to its employees on December 10, 2015 regarding closure of trading window for them for the purposes of consideration and approval of the audited financial results from December 16, 2015 until 24 hours from the publication of the audited financial results for the quarter and year ended December 31, 2015.
Piramal Enterprises acquires five OTC brands for Rs92 crore
Piramal acquires these brands from Organon India Pvt. Ltd and MSD BV, Indian subsidiaries of US-based pharmaceutical leader Merck and Co.